BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Digital Innovation

Thermo Fisher Partners with OpenAI to Accelerate Drug Development through Artificial Intelligence

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s pro...

October 17, 2025 | News

Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems

Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...

October 15, 2025 | Interview

Roche and OASES Partner to Advance Healthcare Innovation in Hong Kong

Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and stre...

October 13, 2025 | News

Kadisco General Hospital and MindHYVE.ai™ Partner to Pioneer AI-Driven Healthcare Transformation in Ethiopia

Kadisco General Hospital (KGH), one of Ethiopia's leading private healthcare institutions, and MindHYVE.ai™, a U.S.-based pioneer in agenti...

October 09, 2025 | News

Made Scientific and Streamline Bio Validate AI-Driven Robotic Platform for Cell Therapy Manufacturing

Made Scientific, a leading clinical and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, a ...

October 07, 2025 | News

Catalent Opens New Global Headquarters in Tampa to Shape the Future of Biopharma Innovation

Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New ...

September 29, 2025 | News

Eli Lilly Opens 82,500-Square-Foot Gateway Labs in San Diego to Support Early-Stage Biotech Innovation

New 82,514 square foot facility will accommodate up to 15 biotech companies to fuel next-generation medicines Gateway Labs model provides flexible l...

September 29, 2025 | News

Hengrui Pharma Grants Glenmark Exclusive Global Licence for HER2-Targeted ADC Trastuzumab Rezetecan

Hengrui Pharma, a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced that it has entered ...

September 25, 2025 | News

Lunit and Agilent Forge Collaboration to Develop AI-Powered Companion Diagnostics

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabili...

September 23, 2025 | News

DEBRA Research and Nonsense Therapeutics Launch ReadOn Therapeutics to Advance Treatments for Epidermolysis Bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for those affected by Epidermolysis bullosa (EB...

September 23, 2025 | News

Thermo Fisher Introduces Hypulse™ System to Transform XPS Depth-Profiling

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This inn...

September 23, 2025 | News

Lenovo Launches GOAST v4.0 Slashing Genome Analysis to 24 Minutes with 3x Higher Throughput

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving discoveries Lenovo shared updates ...

September 22, 2025 | News

Co-Diagnostics Signs Saudi MOU to Establish Joint Venture for PCR Manufacturing and Distribution in the Middle East

The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of th...

September 17, 2025 | News

BioAge Advances BGE-102 into Phase 1 Trials Triggering Milestone Payment to HitGen as DEL Technology Accelerates Drug Discovery

BGE-102, an orally available, brain-penetrant NLRP3 inhibitor, was developed from a hit compound identified using HitGen's industry-leading DEL technolog...

September 16, 2025 | News

Stay Connected